Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)
Clinical trial NCT02449343 · UNKNOWN
Trial details
- NCT number
- NCT02449343
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-12
- Primary completion
- 2017-04-01
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.